• PCR4 Disease-Specific Quality-of-Life Measures Mapped to the EQ-5D in a Chronic Disorder With Recurrent Attacks: Analysis of the Deliver Trial in Patients With Migraine

    Dec 1, 2022, 00:00

  • HSD45 Breast Cancer Biopsy Rates in Chile: Is There Justification for Adopting Innovative Anatomic Pathology Technologies in Public Providers?

    Dec 1, 2022, 00:00

  • CO89 Integrated Analysis of Efficacy and ICU Length of Stay Data From Phase 2 and Phase 3 Trials of Rezafungin for the Treatment of Invasive Candidiasis and/or Candidemia

    Dec 1, 2022, 00:00

  • PCR134 Uncertainties in Evaluating Patient and Caregiver Health-Related Quality of Life and Disease Burden in NICE HST Submissions

    Dec 1, 2022, 00:00

  • EE540 Cost-Effectiveness of Vaccines Targeting Infectious Diseases - Has COVID-19 Changed the Landscape?

    Dec 1, 2022, 00:00

  • EE438 Assessing the Cost-Effectiveness of Axicabtagene Ciloleucel Compared With Other CAR T-Cell Therapies in the Treatment of Diffuse Large B-Cell Lymphoma in the UK

    Dec 1, 2022, 00:00

  • SA50 Claims-Based Estimates of Bleeding Rates in Hemophilia B Patients on Factor IX Therapy in the United States

    Dec 1, 2022, 00:00

  • MSR11 Evaluating the Impact of Exact Logistic Regression on Matching Adjusted Indirect Comparisons (MAICs) of Treatments Between Trials: A Simulation Study

    Dec 1, 2022, 00:00

  • HPR98 Availability and Reimbursement of Multiple Myeloma Drug Regimens in Spain

    Dec 1, 2022, 00:00

  • MSR58 How Do Mapping Studies Take into Account the Methodological Challenges of Repeated Measurements From the Same Individuals Over Time?

    Dec 1, 2022, 00:00

  • PCR42 Examination of Quality of Life and Sexual Functions Among Women With Cervical Cancer

    Dec 1, 2022, 00:00

  • PCR118 Valuation of the EQ Health and Well-being Short Using Time Trade-Off and Discrete Choice Experiments: A Feasibility Study

    Dec 1, 2022, 00:00

  • PCR115 Measurement of Therapeutic Adherence in Orphan Diseases: A Scoping Review

    Dec 1, 2022, 00:00

  • SA82 A Bayesian Network Meta-Analysis of the Tyrosine Kinase Inhibitors (TKI) for ALK-Positive Advanced Non-Small Cell Lung Cancer With or Without Brain Metastasis

    Dec 1, 2022, 00:00

  • MSR126 Economic and Humanistic Burden in Patients With Obstructive Hypertrophic Cardiomyopathy - A Systematic Literature Review

    Dec 1, 2022, 00:00

  • PCR100 Reading and Labeling Medical Discharge Summaries Using Artificial Intelligence to Improve Medical Discharge Process

    Dec 1, 2022, 00:00

  • RWD62 PAP Smear Screening Trend and Disparity in the US, 2016 – 2020

    Dec 1, 2022, 00:00

  • PCR215 Quality of Life Study of Adult Population With Inflammatory Bowel Disease

    Dec 1, 2022, 00:00

  • EPH201 Systematic Review of the Accuracy of T-Cell Receptor Excision Circle (TREC)-Based Newborn Screening for Severe Combined Immunodeficiency (SCID)

    Dec 1, 2022, 00:00

  • EE221 Healthcare Resource Utilization and Costs of Myotubular Myopathy in England

    Dec 1, 2022, 00:00

  • PCR116 Quality of Life of and Economic Burden on Caregivers of Individuals With Sickle Cell Disease in the UK and Fran A Cross-Sectional Survey

    Dec 1, 2022, 00:00

  • SA44 Meta-Analysis of Time-to-Event Oncology Outcomes for Health Economic Modelling

    Dec 1, 2022, 00:00

  • MT6 Real World Clinical Data on the Use of a Natural Molecular Complex for the Treatment of Irritable Bowel Syndrome in Specialist Daily Practice

    Dec 1, 2022, 00:00

  • Innovative Methods in Indirect Treatment Comparisons

    Dec 1, 2022, 00:00

  • RWD111 Influenza Vaccine Sales During the COVID-19 Era

    Dec 1, 2022, 00:00

  • HPR13 Impact of Income Shock on Health Care Utilization of Rural Residents in China - Evidence From CHARLS

    Dec 1, 2022, 00:00

  • HTA259 Overlaps and Differences in the PICO Criteria Between the Different EU Countries

    Dec 1, 2022, 00:00

  • EPH143 Hepatic Disorders of Pirfenidone or Nintedanib in Patients with Idiopathic Pulmonary Fibrosis (IPF): A Systematic Review

    Dec 1, 2022, 00:00

  • PCR212 Symptoms and Impacts Important to Patients With Advanced/Metastatic Non-Small Cell Lung Cancer (adv/met NSCLC): Results of a Qualitative Research Study

    Dec 1, 2022, 00:00

  • EE45 Budget Impact Analysis of Introducing Amino Acid Formula to Infants With Cow's Milk Protein Allergy in Egypt

    Dec 1, 2022, 00:00

  • EE343 Assessing Impact of Kidney Cancer-Related Premature Mortality and Productivity Loss in Greece and Portugal

    Dec 1, 2022, 00:00

  • HPR10 Building Bridges Between Regulation, Health Technology Assessment and Clinical Guideline Development

    Dec 1, 2022, 00:00

  • PCR280 Development of a Patient-Reported Outcome Measure to Evaluate Self-Perception and Psychosocial Impact in Adolescents and Young Adults With Acne

    Dec 1, 2022, 00:00

  • HTA93 The Impact of the EU-JCA Throughout European Healthcare Systems

    Dec 1, 2022, 00:00

  • MSR97 Systematic Literature Review of the Efficacy and Safety of Pharmacological Treatments and Septal Reduction Therapies for Obstructive Hypertrophic Cardiomyopathy

    Dec 1, 2022, 00:00

  • HPR15 Out-of-Pocket Pharmaceutical Payments and Their Poverty Impact on Patients in Greece

    Dec 1, 2022, 00:00

  • EPH30 Disability-Adjusted Life Years Lost Due to Migraine: A Nationwide Burden-of-Illness Study From the National Health Survey in Spain

    Dec 1, 2022, 00:00

  • CO92 Systematic Review of Currently Available Therapies for Crohn's Disease and Ulcerative Colitis

    Dec 1, 2022, 00:00

  • EE154 Reassessment of a Cost-Effectiveness Analysis of Etonogestrel Implant Compared to Other Contraceptive Methods Based on Real Life Data in France

    Dec 1, 2022, 00:00

  • HTA31 Understanding Pricing and Reimbursement Conditions to Facilitate PR Negotiations in Spain: A 5-Year Review (2017-2022)

    Dec 1, 2022, 00:00

  • CO69 A Systematic Literature Review (SLR) of the Clinical Evidence for Treatment of Differentiated Thyroid Cancer (DTC) After Prior Systemic Therapy

    Dec 1, 2022, 00:00

  • OP4 Training Needs Assessment to Improve Regulatory Compliance and Professional Competency in the Pharmaceutical Industry

    Dec 1, 2022, 00:00

  • RWE Applications in Health Technology Assessment

    Dec 1, 2022, 00:00

  • RWD99 The Financial Burden of DM on the Public Health System of Gree Using Big Data From Greece

    Dec 1, 2022, 00:00

  • HPR76 Implementing the Recovery and Resilience Fund Initiative to Reduce Pharmaceutical Expenditure Clawback in Gree The Impact on Pharmaceutical Spending and on National Economy

    Dec 1, 2022, 00:00

  • EPH199 Epidemiology of Eye Disorders Due to the Use of Video Display Terminals in France, Germany, Italy, Spain and United Kingdom – A Systematic Literature Review

    Dec 1, 2022, 00:00

  • HPR49 Are Countries Using ATC Classification and Defined Daily Dose for Pricing and Reimbursement Decisions of Pharmaceuticals?

    Dec 1, 2022, 00:00

  • EE130 Cost-Utility of Cabonivo vs Sunitinib, Pazopanib and Ipinivo for First Line Advanced Renal-Cell Carcinoma in the Private Healthcare System in Brazil

    Dec 1, 2022, 00:00

  • HSD98 Effects of Process Changes on Emergency Department Crowding in a Changing World: An Interrupted Time-Series Analysis

    Dec 1, 2022, 00:00

  • EE595 Did We Follow the Right Approach in Economic Evaluations by Discounting Health Gain?

    Dec 1, 2022, 00:00

  • MSR61 Lessons Learned From Network Meta-Analysis of Survival Data With Fractional Polynomials

    Dec 1, 2022, 00:00

  • HTA199 The Reality of Living Systematic Literature Reviews to Support Timely Healthcare Decisions: A Case Study in Relapsed/Refractory Multiple Myeloma

    Dec 1, 2022, 00:00

  • EE570 Estimation of Direct Medical Costs Associated With Genetic Consultations Among Moroccan Children With Rare Diseases: A Single-Center Retrospective Cost Analysis

    Dec 1, 2022, 00:00

  • EPH112 Assessment of Consumption of Antidepressants in Ukraine Compared With Estonia

    Dec 1, 2022, 00:00

  • EE287 Indirect Costs of Multiple Myeloma in Portugal

    Dec 1, 2022, 00:00

  • EE321 Use of Single-Arm Trials in NICE Reviews of Oncology Drugs

    Dec 1, 2022, 00:00

  • EE433 Cost-Effectiveness Analysis of a New Second-Line Treatment for Advanced Intrahepatic Cholangiocarcinoma in Taiwan: Genetic Test-Based Targeted Therapy of Pemigatinib Versus Chemotherapy of 5-FU

    Dec 1, 2022, 00:00

  • PCR108 Using the Medication Adherence Reasons Scale (MAR-SCALE) in Asthma and Chronic Obstructive Pulmonary Disease to Identify and Describe Reasons for Non-Adherence in 5 European Countries

    Dec 1, 2022, 00:00

  • HSD89 Early Detection of Breast Cancer in Indonesia: Barriers Identified in a Qualitative Study

    Dec 1, 2022, 00:00

  • EE496 Triple Negative Breast Cancer-Related Mortality in Central and Eastern Europe: Years of Life Lost and Productivity Costs

    Dec 1, 2022, 00:00

  • HTA190 Discrete Event Simulation Model for Real-World Restricted Treatment Policies in End-Stage Heart Failure

    Dec 1, 2022, 00:00

  • EPH59 Physicians’ Preferences for the Medical Management of Subarachnoid Hemorrhage Post Aneurysm Repair

    Dec 1, 2022, 00:00

  • CO99 Does Use of Digital Health Interventions in Diabetes Improve Patient Outcomes? Evidence From a Targeted Literature Review

    Dec 1, 2022, 00:00

  • CO88 The Impact of COVID-19 Pandemic on Health-Related Quality of Life Outcomes: Evidence From a Longitudinal Study on Children With Rare Disorders

    Dec 1, 2022, 00:00

  • CO126 Axicabtagene Ciloleucel for the Treatment of B-Cell Lymphoma- Gaps, Opportunities and Future Perspectives

    Dec 1, 2022, 00:00

  • HPR32 The Payers’ and Clinicians' Approach to Burden of Disease and Unmet Health Need in a Rare Disease in Poland, Greece, and the Czech Republic - Similarities and Differences

    Dec 1, 2022, 00:00

  • RWD117 Body Surface Area of Adult Cancer Patients: An Italian Multicenter Retrospective Study

    Dec 1, 2022, 00:00

  • EE315 Cost-Effectiveness Analysis of Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes in China

    Dec 1, 2022, 00:00

  • HTA121 Opportunities and Challenges of Cross-Country Collaborations in Market Access of Medicines: Stakeholder Perspectives on the BeNeLuxA Initiative

    Dec 1, 2022, 00:00

  • EE410 Examining the Cost-Effectiveness of Biomarker Testing in Oncology Studies: Should the Health Systems Invest in It?

    Dec 1, 2022, 00:00

  • EPH191 The Epidemiology of Male Breast Cancer in Eight High-Income European Countries

    Dec 1, 2022, 00:00

  • HTA24 Real-World Data as External Controls for Single-Arm Trials: Role in Regulatory and Health Technology Assessments

    Dec 1, 2022, 00:00

  • HTA153 HTA Requirements in Central Eastern European Countries

    Dec 1, 2022, 00:00

  • MT35 The Economic and Capacity Impact of Time Saved in the Operating Theatre Performing Holmium Laser Enucleation of the Prostate with Moses™ Technology vs Standard Technology

    Dec 1, 2022, 00:00

  • SA69 Differences in Evidence Requirements of HTA Authorities in UK, Italy, Netherlands, Poland, Portugal, and Sweden to Appraise New Products

    Dec 1, 2022, 00:00

  • EPH58 A Theoretical Estimation of the Future Prevalence of Osteoporosis in Patients Undergoing Spine Fusion Surgery in Japan by 2050

    Dec 1, 2022, 00:00

  • EE213 Cost-Effectiveness Analysis of Trastuzumab Deruxtecan for Patients With HER2+ Metastatic Breast Cancer

    Dec 1, 2022, 00:00

  • EE210 Epidemiology, Patients’ Characteristics and Healthcare Costs in Early-Stage Non-Small-Cell Lung Carcinoma: A Real-World Analysis in Italy

    Dec 1, 2022, 00:00

  • EE400 Comparing the Budget Impact of Selective Internal Radiation Therapy Using Y-90 Resin Microspheres Versus Drug Eluting Bead Transarterial Chemoembolization in Hepatocellular Carcinoma in England

    Dec 1, 2022, 00:00

  • PCR41 Is Enhancing Health-Related Quality of Life Correlated to Direct-Acting Antivirals Adherence in Chronic Hepatitis C Virus Patients? A Romanian Prospective Cohort Study

    Dec 1, 2022, 00:00

  • EPH15 Epidemiology of Patients Revascularized for Peripheral Artery Disease in France (2016-19): A Retrospective Observational Cohort Study Using the French Hospital Discharge Database (PMSI)

    Dec 1, 2022, 00:00

  • EE340 Impact of Quality of Evidence on Cost-Effectiveness Outcomes for New Products: Pilot Study for a Hypothetical New Therapy for HR+/HER2- Metastatic Breast Cancer (MBC)

    Dec 1, 2022, 00:00

  • EPH69 Health Inequity in Viral Infections in a Medicaid Population: Lessons From Influenza and COVID-19

    Dec 1, 2022, 00:00

  • EE627 Inclusion of Environmental Sustainability in the Economic Analysis of Healthcare Interventions: A Review of Policy Approaches

    Dec 1, 2022, 00:00

  • EPH196 Evaluation of Parents’ Attitude Toward Vaccines

    Dec 1, 2022, 00:00

  • EPH110 Years of Potential Life Lost Due to Cervical Cancer: A Challenge for Hungarian Screening Strategy

    Dec 1, 2022, 00:00

  • HPR127 Managing Uncertainty for the Orphans: A Belgian Perspective on Managed Entry Agreements for Orphan Drugs

    Dec 1, 2022, 00:00

  • EE243 Cost-Effectiveness Model Conceptualisation in Fibrodysplasia Ossificans Progressiva

    Dec 1, 2022, 00:00

  • CO73 Amivantamab Versus Real-World Clinical Practice in Europe and the US for Patients With Advanced Non-Small Cell Lung Cancer With Activating Epidermal Growth Factor Receptor Exon 20 Insertion Mutations

    Dec 1, 2022, 00:00

  • HPR157 Repurposed Drugs Launched Under the AMNOG in Germany: Effects on Benefit Assessment and Price Development

    Dec 1, 2022, 00:00

  • RWD145 The Direct Cost Savings and Indirect Value of Using Artificial Intelligence With Clinical Disease Specific Quality Register Data - Case Helsinki University Eye Clinic: Cataract Register and Retina Register

    Dec 1, 2022, 00:00

  • RWD33 Analysis of COVID-19 Vaccine-Related Adverse Events in Adults, Geriatrics and Pediatrics – A Retrospective Study

    Dec 1, 2022, 00:00

  • HTA43 Multi-Country HTA Initiatives Versus National HTA Processes: The Optimal Reimbursement Strategy

    Dec 1, 2022, 00:00

  • HTA172 External Control Arm Studies in the Context of Pricing and Reimbursement Assessments – Overview on Guidance and Evaluation in Europe

    Dec 1, 2022, 00:00

  • RWD104 Delayed Diagnosis Amongst gMG Patients: Results From a European Real-World Study

    Dec 1, 2022, 00:00

  • EE218 Cost-Utility Analysis Comparing Robot-Assisted Radical Prostatectomy Versus Robotic Stereotactic Body Radiotherapy With Artificial Intelligence for the Treatment of Prostate Cancer

    Dec 1, 2022, 00:00

  • HPR14 Identifying the Key Drivers of Biosimilar Uptake in Paris University Hospitals Using a Principal Component Analysis

    Dec 1, 2022, 00:00

  • EPH47 Early Hospital Management of Ageing Disease: Retrospective Study From a National Claims Database

    Dec 1, 2022, 00:00

  • HSD53 Analysis of the Balanced Scorecard's Internal Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • CO37 Reduction of Length of Hospital Stay in Patients Undergoing Major Planned Orthopedic Surgery After the Implementation of the Patient Blood Management (PBM) in Italy

    Dec 1, 2022, 00:00

  • HPR31 Analysis of the Difference Between Tender and Reimbursement Prices of Cardiovascular Surgery Medical Devices in Turkiye Between 2017-2021

    Dec 1, 2022, 00:00

  • EPH194 Risk Factors Affecting Caries Development Among Primary School Children

    Dec 1, 2022, 00:00

  • RWD64 Identifying Patient-Level Social Determinants of Health in Unstructured Clinical Notes From Electronic Health Records

    Dec 1, 2022, 00:00

  • MSR99 Cartography of Biostatistics and Machine Learning Methods to Identify Prognostic Factors

    Dec 1, 2022, 00:00

  • EE334 Cost-Effectiveness Analysis of Nivolumab as an Adjuvant Treatment of Muscle-Invasive Urothelial Carcinoma at High Risk of Recurrence in Greece

    Dec 1, 2022, 00:00

  • PCR55 Development and Application of a Novel Systematic Method to Identify Patients’ Unmet Needs: A Pilot Study in Inflammatory Bowel Disease

    Dec 1, 2022, 00:00

  • PCR290 Patient Preferences and Cost-Benefit of Hypertension and Hyperlipidemia Collaborative Management Model Between Pharmacies and Primary Care in Portugal: A Discrete Choice Experiment Alongside a Trial (USFARMÁCIA®)

    Dec 1, 2022, 00:00

  • EPH84 Prevalence of Polysubstance Use of Opioids in Pregnant Women and Medication-Assisted Treatment: Evidence from the United States Treatment Episode Data Set

    Dec 1, 2022, 00:00

  • EE424 Picking Petals Off the Value Flower – The Need to Consider Insurance Value for New Medical Technologies

    Dec 1, 2022, 00:00

  • EE92 Economic Evaluation of Isavuconazole Versus Voriconazole for the Treatment of Patients With Possible Invasive Aspergillosis in the Brazilian Private Healthcare System

    Dec 1, 2022, 00:00

  • SA32 Adapting PROs Evaluation to COVID Context – The Case of ASCEND Study

    Dec 1, 2022, 00:00

  • HSD14 Lacking Observance of the Guidelines on Dyslipidaemias as Possible Reason for Low LDL-C Goal Attainment in Patients at High and Very High Cardiovascular Risk

    Dec 1, 2022, 00:00

  • MT9 Cost-Utility of Bone Conduction Implants for Conductive or Mixed Hearing Loss or Single-Sided Deafness: A Decision Analysis

    Dec 1, 2022, 00:00

  • EE263 Cost-Effectiveness Analyses (CEAs) of CAR-T Therapies Over the Past Four Years: What's New?

    Dec 1, 2022, 00:00

  • HPR25 Patient Organisations' Submissions to the Pharmaceutical Pricing Board in Finland

    Dec 1, 2022, 00:00

  • EPH66 Underground Economy - A Parameter of Social Influence During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • PCR105 Examination of Surgical Indications and Previous Hip Replacement Surgery Among Hip Prosthesis Patients in State and Private Health Care

    Dec 1, 2022, 00:00

  • CO25 Efficacy of Targeted Drugs for the Treatment of Adults With Moderate-to-Severe Plaque Psoriasis in the Russian Federation: A Systematic Literature Review Update

    Dec 1, 2022, 00:00

  • EPH166 Idiopathic Pulmonary Fibrosis (IPF : Epidemiology and Characteristics of Patients in Morocco

    Dec 1, 2022, 00:00

  • EE308 Budget Impact Analysis (BIA) of Medical Activity on Fractional Flow Reserve Measurement (FFR) for Functional Assessment of Epicardial Stenoses in Patients With Stable Coronary Heart Disease

    Dec 1, 2022, 00:00

  • CO87 Reductions in Exacerbations and Improvements in Lung Function and Asthma Control in Children With Moderate-to-Severe Type 2 Asthma Analyzed by High- or Medium-Dose of Inhaled Corticosteroids at Baseline

    Dec 1, 2022, 00:00

  • P31 Estimating Subgroup- And Individual-Level Treatment Effects Using Machine Learning

    Dec 1, 2022, 00:00

  • CO134 Systematic Review of the Impact of Early Versus Late Diagnosis and/or Hematopoietic Stem Cell Transplantation (HSCT) for Severe Combined Immunodeficiency (SCID)

    Dec 1, 2022, 00:00

  • HSD1 Treatment With Dual and Triple Therapy in Chronic Obstructive Pulmonary Disease in Line With Current Guidelines Reduces the Carbon Footprint

    Dec 1, 2022, 00:00

  • EPH177 Assessing Student Pharmacists’ Knowledge and Perceptions of Electronic Nicotine Delivery Systems (ENDS) – A Cross Sectional Study at One College of Pharmacy

    Dec 1, 2022, 00:00

  • PCR88 How Does the Quality of Life of Hip Replacement Patients Operated in State and Private Health Care Change in the Postoperative Period?

    Dec 1, 2022, 00:00

  • EE236 Hospital Incidence and Medical Costs of Polycythemia Vera in Spain: A Retrospective Database Analysis

    Dec 1, 2022, 00:00

  • The Role of Real-World Data in HTA and Regulatory Decision-Making

    Dec 1, 2022, 00:00

  • EE407 Budget Impact Analysis of the Use of Emicizumab in Prophylaxis for Severe Hemophilia A and Inhibitors in the Pediatric Population of the Dominican Republic

    Dec 1, 2022, 00:00

  • Improving Accuracy, Validity, and Uncertainty of Simulation Models

    Dec 1, 2022, 00:00

  • CO17 Real-World Data (RWD) Collection Alongside Early Access to Medicines Scheme (EAMS) - Nivolumab in Advance Squamous Cell Oesophageal Cancer After Prior Chemotherapy

    Dec 1, 2022, 00:00

  • HPR173 Criteria to Define Rare Diseases and Orphan Drugs: Systematic Literature Review

    Dec 1, 2022, 00:00

  • CO12 Prevalence and Factors Associated With Hypoparathyroidism After Total Thyroidectomy for Thyroid Cancer: A French Nationwide Claims Database Study

    Dec 1, 2022, 00:00

  • HTA6 Evaluation of Ethical Aspects Associated With Health Technology: Lessons Learnt From Indian HTA Reports

    Dec 1, 2022, 00:00

  • PCR28 Utility Values Derived From Canadian Adults With Toenail Onychomycosis With and Without Comorbid Diabetes Mellitus: A Study Using the Health Utilities Index®

    Dec 1, 2022, 00:00

  • RWD91 The Burden of Fall by Cause and Injury Type in Older Populations and Its Impact on Healthcare Utilization in the US

    Dec 1, 2022, 00:00

  • RWD81 Analysis of Clinical Outcomes, Health Resource Use and Costs of Patients With Non-Valvular Atrial Fibrillation Treated With Apixaban vs Acenocoumarol in Routine Clinical Practice in Spain

    Dec 1, 2022, 00:00

  • HTA104 Opportunities to Improve the Adoption of Quality of Life Data as Part of the French Health Technology Assessment Process

    Dec 1, 2022, 00:00

  • CO57 Modeling Adherence to Positive Airway Pressure Therapy in Women With Obstructive Sleep Apnea

    Dec 1, 2022, 00:00

  • EE667 The Opportunity of High-Dose Vaccination Against Influenza for Adults Aged 60 and Above in the Netherlands

    Dec 1, 2022, 00:00

  • EE99 Cost-Effectiveness of Percutaneous Closure of a Patent Foramen Ovale (PFO) Versus Antiplatelet Therapy After Stroke: A Trial and Model Based Economic Evaluation of the French Close Randomised Controlled Trial

    Dec 1, 2022, 00:00

  • EE299 Cost-Effectiveness of Left Ventricular Assist Devices (LVAD) as Destination Therapy: A Systematic Review

    Dec 1, 2022, 00:00

  • RWD25 The Phollow Cohort: Real-World Therapeutic Adherence to Blood Glucose Lowering Drugs (Excluding Insulins) in Portugal

    Dec 1, 2022, 00:00

  • SA28 Unique Device Identifiers for Cardiac Implantable Electronic Devices – A Data Quality Assessment of Administrative Hospital Data in Portugal

    Dec 1, 2022, 00:00

  • MSR51 Predictors of Hospitalization in Patients With Newly Diagnosed Major Depressive Disorder: A Real-World Evidence Study

    Dec 1, 2022, 00:00

  • EE414 Cost-Effectiveness of Mobile Intermittent Pneumatic Compression Devices (IPCD) Compared to Traditional IPCD for Early Postoperative Total Knee Replacement: The Hospital’s Perspectives

    Dec 1, 2022, 00:00

  • HPR80 Assessing Performance of TB Management Through NTEP By 2025: An Initiative From the Indian Government a Roadmap Ahead of Sustainable Goal in India 2030

    Dec 1, 2022, 00:00

  • MT39 Factors Influencing the Uptake of Magnetic Resonance Imaging-Guided High Intensity Focused Ultrasound for Painful Bone Metastases in Europe: A Group Concept Mapping Study

    Dec 1, 2022, 00:00

  • HTA260 Informal Carer Disutility: How Many Caregivers Are Captured in Cost-Utility Analyses of Treatments for Rare Diseases Submitted for NICE Highly Specialised Technology Appraisals?

    Dec 1, 2022, 00:00

  • PCR34 Demographic Analysis of Cancer Patients Who Voluntarily Used a Digital Health Tool to Self-Report Medications, Symptoms and Well-Being

    Dec 1, 2022, 00:00

  • EE66 Tiered Pricing and Other Alternative Mechanisms for Equitative Access to Vaccines in Latin America: A Narrative Review of the Literature

    Dec 1, 2022, 00:00

  • Meeting

    Dec 1, 2022, 00:00

  • MSR105 Artificial Intelligence/Machine Learning (AI/ML) Techniques for Risk/Outcomes Prediction in Patients With Myocardial Infarction (MI) – A Targeted Literature Review (TLR)

    Dec 1, 2022, 00:00

  • PCR128 Patient-Reported Symptoms Are the Sole Independent Predictor of the Societal Burden Associated With Inflammatory Bowel Disease: A Cross-Sectional Study

    Dec 1, 2022, 00:00

  • EE143 Cost-Effectiveness of Ofatumumab Compared with Other Disease-Modifying Therapies for the Treatment of Relapsing Multiple Sclerosis in Greece

    Dec 1, 2022, 00:00

  • EPH163 Burden of Diffuse Large B-Cell Lymphoma (DLBCL) in Germany – A Retrospective Statutory Health Insurance Claims Data Analysis

    Dec 1, 2022, 00:00

  • P59 Automated Literature Screening Using Artificial Intelligen A Meta-Analysis of Different Algorithm Results

    Dec 1, 2022, 00:00

  • EE670 Using an Efficiency Frontier Approach to Generate Value Bases Price Estimates for a Transformational TPP

    Dec 1, 2022, 00:00

  • CO97 Assessment of Enhanced Efficacy of Multiple CYTOPOINT Injections

    Dec 1, 2022, 00:00

  • EE428 Cost-Effectiveness of Collagen Laminin-Based Dermal Matrix Combined With Resveratrol Microparticles in Treatment of Diabetic Foot Ulcer Treatment in Turkey

    Dec 1, 2022, 00:00

  • EPH119 The Economic Burden of Illness (BOI) of the Globally Spreading Chikungunya Virus (CHIKV): A Systematic and Targeted Literature Review (SLR AND TLR)

    Dec 1, 2022, 00:00

  • MSR13 Methods for Handling EQ-5D Missing Values in Cost-Effectiveness Analyses (CEA) and Patient-Reported Outcome (PRO) Studies: A Targeted Literature Review

    Dec 1, 2022, 00:00

  • MSR127 Generalizability of Trial-Based Economic Evaluations. Methods to Account for Covariates and Impact on Cost-Effectiveness and Value of Information

    Dec 1, 2022, 00:00

  • EPH158 Examination of the Glenohumeral Joint and Rotator Cuff Condition Among Youth Kayak-Canoe Athletes

    Dec 1, 2022, 00:00

  • EPH64 Public Health Impact of COVID-19 in French Ambulatory Patients With at Least One Risk Factor for Severe Disease

    Dec 1, 2022, 00:00

  • HTA227 A Cross-Stakeholder Approach to Support the Acceptance of Non-Os Endpoints in Reimbursement Decision Making

    Dec 1, 2022, 00:00

  • MSR76 Evaluation of the Use of Topic Modelling (TM) to Support Systematic Literature Review (SLR) Updates for Screening Truncation of Non-Relevant Citations

    Dec 1, 2022, 00:00

  • HTA270 Use of Patient Preference Studies to Support HTA Submissions in Oncology

    Dec 1, 2022, 00:00

  • RWD159 Use of RWD to Support Healthcare Decision Making in Japan: The Devil Lies in the 'D' - How Is the Data Landscape Evolving in Japan?

    Dec 1, 2022, 00:00

  • RWD39 Using Linked Databases to Explore Resource Use and Real-World Outcomes in a Rare Disease: Fabry Disease in England

    Dec 1, 2022, 00:00

  • EE23 Costs, Consequences and Budget Impact of Implementing a 2-Dose or 3-Dose Rotavirus Vaccine in the United Kingdom

    Dec 1, 2022, 00:00

  • PCR170 Mapping IWQOL-Lite Onto EQ-5D-5L and SF-6DV2 in Chinese Overweight and Obese Population

    Dec 1, 2022, 00:00

  • PCR270 Disparities in Mammography Screening: Motivations of Individuals or Structural Racism?

    Dec 1, 2022, 00:00

  • HPR189 Estimating the Impact of Generic Drug Entry on Cost Effectiveness of New Drugs

    Dec 1, 2022, 00:00

  • EPH88 Determinants of Caregiving Burden Among Caregivers of Adult Patients With Beta-Thalassemia Major in China

    Dec 1, 2022, 00:00

  • EE505 Systematic Literature Review of Economic Evaluations for 1L Treatment of Advanced/Metastatic NSCLC in the EU5

    Dec 1, 2022, 00:00

  • HSD60 TRENDSTM Knowledge and Attitudes of Pharmacists Regarding Infectious Diseases and Antimicrobial Resistance in Hungary: Questionnaire-Development, Validation and a Quantitative, Cross-Sectional Study

    Dec 1, 2022, 00:00

  • EE185 Cost-Effectiveness of Transcatheter Aortic Valve Implantation in Low Surgical Risk Patients With Severe Symptomatic Aortic Stenosis in Germany

    Dec 1, 2022, 00:00

  • EE138 Healthcare Resource Use (HCRU) and Associated Costs Among Patients With Diffuse Large B-Cell Lymphoma (DLBCL) Treated with CAR-T Cells in France – A Real-World Study Using Data From PMSI

    Dec 1, 2022, 00:00

  • PCR110 International X-Linked Hypophosphataemia (XLH) Registry: Capturing Patient-Reported Outcome Data

    Dec 1, 2022, 00:00

  • SA49 Long-Term Follow-Up of Patients Treated With Cell and Gene Therapy: Scientific and Operational Challenges

    Dec 1, 2022, 00:00

  • EE614 Use of Value of Information in the Context of the Cancer Drug Fund in the UK

    Dec 1, 2022, 00:00

  • HSD50 Evaluating the Pediatric Prescribing Pattern in a Health Facility in Nigeria

    Dec 1, 2022, 00:00

  • EE164 Cost-Effectiveness of Neuromuscular Electrical Stimulation for the Treatment of Mild Obstructive Sleep Apnea: An Exploratory Analysis

    Dec 1, 2022, 00:00

  • P23 Bayesian Calibration of a Simulation Model of Opioid Use Disorder

    Dec 1, 2022, 00:00

  • HSD4 Is the National Training Programme for Laparoscopic Colorectal Surgery (LAPCO) Value for Money?

    Dec 1, 2022, 00:00

  • A Scoping Review of the Use of Machine Learning in Health Economics and Outcomes Research: Part 2—Data From Nonwearables [Editor's Choice]

    Dec 1, 2022, 00:00

  • EE184 Assessing the Cost-Effectiveness of the Novavax COVID-19 Vaccine as a Potential Booster Vaccine Option for Adults in the United States

    Dec 1, 2022, 00:00

  • HTA159 Inconsistencies in Measurement of Health-Related Quality of Life (HRQoL)/ Patient-Reported Outcomes (PROs) in Rare Skin Diseases (RSDs)

    Dec 1, 2022, 00:00

  • MSR5 Temporal Uncertainty and Decision-Making in Cost-Effectiveness Models

    Dec 1, 2022, 00:00

  • EPH46 Three-Year Epidemiology, Economic Burden and All-Cause Mortality Among Palmoplantar Pustolosis Patients: A Canadian Incidence Study of Inpatient Care, Emergency Departments, and Hospital- or Community-Based Outpatient Clinics

    Dec 1, 2022, 00:00

  • PCR140 Higher Need for Medical and Societal Resources of Moderately-to-Severely Affected Myasthenia Gravis Patients in Comparison to the General Population: Analysis of Digitally Collected Observational Data From 8 Countries

    Dec 1, 2022, 00:00

  • CO152 Clinical Predictors of Axicabtagene Ciloleucel (AXI-CEL) Therapy for Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): A Systematic Literature Review (SLR) and Meta-Analysis

    Dec 1, 2022, 00:00

  • EE289 A Study of Post Operation Hypotension Burden Model in Korea Using Hira National Inpatient Sample (HIRA-NIS) Data

    Dec 1, 2022, 00:00

  • OP3 Experience in Assessing Students’ Knowledge on TBL Methodology

    Dec 1, 2022, 00:00

  • EE193 Lorlatinib as a First-Line Treatment for ALK+ Advanced Non-Small Cell Lung Cancer: A Cost-Effectiveness Analysis in Spain

    Dec 1, 2022, 00:00

  • HTA195 Analysis of Health Technology Assessment (HTA) Procedures and Outcomes for Orphan Drugs

    Dec 1, 2022, 00:00

  • HTA183 AMNOG Benefit Assessment in Germany: Outcomes From 2011 to 2022

    Dec 1, 2022, 00:00

  • MSR60 Literature Review of Statistical Methods Comparisons Through Simulations When Using External Control Arm for Regulatory or HTA Submissions

    Dec 1, 2022, 00:00

  • HTA72 Examining the Effectiveness of the Cancer Drugs Fund: Are Data Collection Plans Working as Intended?

    Dec 1, 2022, 00:00

  • PCR187 Assessing Treatment Needs and Outcomes in Patients With Parkinson’s Disease: Results From a Real-World Study

    Dec 1, 2022, 00:00

  • HPR150 PR Policies and Macro-Trends Pertinent to CGTs: Where Are the Main Barriers and Who Leads the Efforts to a Greater Access?

    Dec 1, 2022, 00:00

  • HTA137 Evidence Review Group Criticism of Clinical Effectiveness Systematic Reviews in NICE Oncology Submissions

    Dec 1, 2022, 00:00

  • MT29 Advantages of 3D Visualization Systems for Teaching in Ophthalmology

    Dec 1, 2022, 00:00

  • HPR50 Challenges That EUnetHTA21 Will Have to Address to Make a Success of Joint Clinical Assessments

    Dec 1, 2022, 00:00

  • EE550 The Potential Cost and Cost-Effectiveness Impact of Using Machine Learning Sepsis Prediction Algorithm for Early Detection of Sepsis in Intensive Care Units in Sweden and the United Kingdom

    Dec 1, 2022, 00:00

  • RWD156 Long- and Short-Acting Methylphenidate Consumption in South Africa

    Dec 1, 2022, 00:00

  • HSD7 Analysis of the Balanced Scorecard's Knowledge and Growth Subdimensions in Health Care Organizations During the COVID-19 Pandemic

    Dec 1, 2022, 00:00

  • HSD33 Good Adherence to Pay-for-Performance and Continuity of Care Reduced Occurrence of Surgery-Needed Diabetic Retinopathy: A Population-Based Cohort Study of 4 Years

    Dec 1, 2022, 00:00

  • PCR278 Systematic Review on Health-Related Quality of Life and Utilities in Immunoglobulin A Nephropathy (IgAN)

    Dec 1, 2022, 00:00

  • EE626 Analysis of Healthcare Resource Use of the Robotic Surgery System for Lung Cancer in Japan

    Dec 1, 2022, 00:00

  • EE11 Burden of Myelodysplastic Syndromes Part II: Systematic Literature Review of Economic Burden

    Dec 1, 2022, 00:00

  • EPH164 Estimation of the Burden of C.Difficile Infection in Community and Hospital Settings in France From 2015-2019: Results From a National Health Insurance Database Study (The CLODICIA SNDS Study)

    Dec 1, 2022, 00:00

  • HPR160 Analysis of the Time Spent by AIFA Committees for the Assessment of New Drugs: Impact of the Application of Managed Entry Agreements

    Dec 1, 2022, 00:00

  • EE475 Observational, Retrospective Study on the Evaluation of Direct and Indirect Costs Generated by Multiple Myeloma (MM) in Algeria

    Dec 1, 2022, 00:00

  • EPH170 Is Hyperammonemic Crisis in Inborn Errors of Metabolism an Ultra-Orphan Disease? A Literature Review

    Dec 1, 2022, 00:00

  • RWD125 Demographics and Healthcare Resource Utilization of Patients With Sports-Related Mild Traumatic Brain Injury (SR-MTBI) in the US

    Dec 1, 2022, 00:00

  • EE112 Cost-Effectiveness of Digital Breast Tomosynthesis in Mammography Screening in Women With High Breast Density From a Czech Perspective

    Dec 1, 2022, 00:00

  • PCR191 Classification of Functioning, Disability Health: Validity of Preference-Weighted Scores

    Dec 1, 2022, 00:00

  • PCR188 Unearthing Social Determinants of Health From a Patient-Focused Web Platform

    Dec 1, 2022, 00:00

  • CO102 Systematic Review and Meta-Analysis of Randomized Trials: Efficacy, Immunogenicity, and Safety of Denvax Vaccine

    Dec 1, 2022, 00:00

  • EE328 A Flexible Program Compared to Algorithm-Guided Treatment Program for Depression: A Cost-Effectiveness Analysis

    Dec 1, 2022, 00:00

  • MSR141 Building Bridges: What Pandemic Preparedness Can Learn From Real-Option Value Analyses of Water Infrastructure in the Netherlands

    Dec 1, 2022, 00:00

  • EPH73 Diet Quality During the First Two Years of Life and the Women, Infants and Children Program

    Dec 1, 2022, 00:00

  • EPH37 High Cardiovascular Disease Risk and Low Lipid-Lowering Treatment in Heterozygous Familial Hypercholesterolemia Patients: A French Nationwide Registry

    Dec 1, 2022, 00:00

  • EPH83 An One-Year Static Cross-Sectional Population Model to Assess the Infection Burden Across the Ageing Population: An Application to the Flemish County

    Dec 1, 2022, 00:00

  • RWD43 Early Symptom-Change Contributes to the Outcome Prediction of Cognitive Behavioral Therapy for Depression Patients: A Machine Learning Approach

    Dec 1, 2022, 00:00

  • HSD11 Evaluation of the Implementation Progress of a New Complex Intervention in a Multimorbidity Patient-Centered Care Model in Chile

    Dec 1, 2022, 00:00

  • EE460 A Systematic Review of the Methodological Aspects of Applied Economic Evaluations in the Palliative and End-of-Life Care Settings

    Dec 1, 2022, 00:00

  • HPR117 Meta-Indicators for Analysing Pharmaceutical Systems: The PPRI Indicators

    Dec 1, 2022, 00:00

  • HSD46 Human Resources Costs in Breast Cancer Biopsy Processing in Chile: What's the Impact of Human Resources?

    Dec 1, 2022, 00:00

  • RWD85 Trends in Medicine Utilization and Its Expenditure for Treating Lung Cancer in Catalonia

    Dec 1, 2022, 00:00

  • EPH200 Prevalence and Treatment Patterns of Generalized Pustular Psoriasis (GPP) in Germany – Results of a Delphi Consensus Study

    Dec 1, 2022, 00:00

  • The Use of Generic Patient-Reported Outcome Measures in Emergency Department Surveys: Discriminant Validity Evidence for the Veterans RAND 12-Item Health Survey and the EQ-5D

    Dec 1, 2022, 00:00

  • P2 The Value of Vaccination: Capturing the Impact of Vaccination on Health Equity in Health Economic Analysis

    Dec 1, 2022, 00:00

  • EE399 Exploring the Effect of Different Patient Entry Intervals on Budget Impact Estimations

    Dec 1, 2022, 00:00

  • EE4 Hospital Care of Endometriosis in Spain: A Retrospective Multicenter Analysis of Patient Characteristics and Costs

    Dec 1, 2022, 00:00

  • RWD154 Clinical Characteristics and Pathways of Care of Breast Cancer Patients Receiving Targeted Therapy in Hungary

    Dec 1, 2022, 00:00

  • PCR97 Patient and Caregiver Insight Into the Impact of Non-Muscle Invasive Bladder Cancer and Its Treatments: A Social Media Review

    Dec 1, 2022, 00:00

  • HTA60 Icosapent Ethyl in Addition to Statins Is a Cost-Effective Treatment in Patients at High Cardiovascular Risk With Elevated Triglycerides and Established Cardiovascular Disease or Diabetes With Risk Factor in the Netherlands

    Dec 1, 2022, 00:00

  • MSR130 Comparison of Software for Bayesian Network Meta-Analysis: A Case Study of Binomial Outcomes in Ulcerative Colitis

    Dec 1, 2022, 00:00

  • EE172 The Wisdom Self-Management Intervention: A Cost-Effectiveness Analysis to Support the Transformation of Type 2 Diabetes Care in England

    Dec 1, 2022, 00:00

  • HPR210 Future BeNeLuxA Success – A Partnership vs a Prescription Model

    Dec 1, 2022, 00:00

  • MT38 Economic Value of Antibiotic-Impregnated External Ventricular Drain Catheters in Cerebrospinal Fluid Diversion Procedures

    Dec 1, 2022, 00:00

  • HTA78 Evaluations of Cost-Utility Analyses of Pharmaceuticals Receiving Market Authorization Based on Single-Arm Trials in the Netherlands

    Dec 1, 2022, 00:00

  • EPH173 Current Issues and Expected Challenges in Identification of Depression as a Cardinal Symptom Within Bipolar Disorder

    Dec 1, 2022, 00:00

  • SA70 Survey of Sport-Specific Lower Limb Injuries in 15 of Hungary's Most Popular Sports

    Dec 1, 2022, 00:00

  • RWD137 Changing Priorities Among Physician Reported Reasons for Choice of Pharmacological gMG Treatments Across 5 European Countries

    Dec 1, 2022, 00:00

  • HTA123 An Exploration of Patient Involvement in NICE and SMC Appraisals of Breast and Ovarian Cancer Therapies

    Dec 1, 2022, 00:00

  • MSR120 To Include an Error Once May Be Regarded as a Misfortune, to Include It Again Looks Like Carelessness

    Dec 1, 2022, 00:00

  • HTA252 Analyzing Critical Drivers for Success in the Implementation of Outcome-Based Agreements to Manage Clinical Uncertainty Risks in Spain

    Dec 1, 2022, 00:00

  • PCR239 Physician and Patient Preferences for Oral Anticoagulation Therapy Decision-Making in Atrial Fibrillation: Results From a National Best-Worst Scaling Survey in Turkey (PREF-AF)

    Dec 1, 2022, 00:00

  • EE76 Budget Impact of Subcutaneous Infliximab in Comparison to Intravenous Infliximab in the Management of Autoimmune Diseases in Greece

    Dec 1, 2022, 00:00

  • CO26 Types of the Most Frequent Provider of Ambulatory Diabetes Care and Its Impact on Continuity of Care, Medical Expenses Using National Health Insurance Database of Korea

    Dec 1, 2022, 00:00

  • EPH49 Nosocomial Infections With Methicillin-Resistant Staphylococcus Aureus (SARM) Potentially Avoided With the Use of Dalbavancin During Hospital Treatment of Acute Bacterial Skin and Skin Structure Infections in Spain

    Dec 1, 2022, 00:00

  • RWD30 Cost of Asthma Hospitalizations in the Brazilian Public Health

    Dec 1, 2022, 00:00

  • CO72 Predicting Sojourn Times by Dementia Stages: Evidence From 76,747 Patients in the Swedish National Registry for Cognitive Disorders (SVEDEM)

    Dec 1, 2022, 00:00

  • CO2 Long-Term Survival After an Acute Stroke in Brazil From 2012-2021: A Population-Based Cohort Study From a Healthcare Plan

    Dec 1, 2022, 00:00

  • EPH138 Understanding the Prevalence and Burden of Diabetic Ketoacidosis (DKA) in People With T1DM at High Risk for DKA: A Structured Literature Review

    Dec 1, 2022, 00:00

  • SA46 Using Cloud Computing to Improve the Run-Time of Individual Patient Simulation Models

    Dec 1, 2022, 00:00

  • EPH210 Impact of Distance Learning on Development of Emotional Intelligence of Medical Bachelor Students

    Dec 1, 2022, 00:00

  • CO107 Clinical Outcomes of Patients With Metastatic Renal Cell Carcinoma (MRCC) With or Without Sarcomatoid Differentiation Treated With Systemic Therapy in Real-World Canadian Setting

    Dec 1, 2022, 00:00

  • HTA131 An Early Health Technology Assessment of Non-Invasive Fractional Flow Reserve Versus Standard Diagnostics in Patients With Stable Chest Pain in the Netherlands

    Dec 1, 2022, 00:00

  • PCR172 A Natural Language Processing (NLP) Approach to Automate Patients’ Testimonials Analysis

    Dec 1, 2022, 00:00

  • PCR152 Underutilization of a Validated Treatment Satisfaction Instrument in Inflammatory Bowel Disease

    Dec 1, 2022, 00:00

  • HTA113 Accounting for Caregiver Quality of Life in Cost-Effectiveness Analyses of Rare Genetic Disease of Obesity – A Case Study in the Swedish Context

    Dec 1, 2022, 00:00

  • PCR246 Patient Preferences Regarding Thrombopoietin-Receptor Agonists for Immune Thrombocytopenia in Italy (TRAPeze Italy Study)

    Dec 1, 2022, 00:00

  • EE298 Cost-Effectiveness of Brexucabtagene Autoleucel (Brexu-cel, CAR-T) for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma in Greece

    Dec 1, 2022, 00:00

  • RWD75 Healthcare Cost for Patients With Chronic Rhinosinusitis With Nasal Polyps and Comorbid Asthma

    Dec 1, 2022, 00:00

  • PCR78 Types of Headaches and Their Impact on Everyday Activities

    Dec 1, 2022, 00:00

  • RWD19 Real-World Disease Burden of Chronic Obstructive Pulmonary Disease: A Retrospective Population-Based Cohort Study in Tianjin, China

    Dec 1, 2022, 00:00

  • RWD49 Bias Characterization of Real-World Patients With and Without Imaging in a Community Oncology Electronic Health Records Database

    Dec 1, 2022, 00:00

  • PCR75 Comparing Choice Share Prediction Methods for Discrete Choice Experiments: A Case Study With Hypomethylating Agents in Myelodysplastic Syndromes

    Dec 1, 2022, 00:00

  • EE222 Evaluating the Budget Impact on the Health Care System in England and Wales of RefluxStop as a Treatment for Refractory Gastroesophageal Reflux Disease (GORD)

    Dec 1, 2022, 00:00

  • PCR131 Resilience, and Positive Parenting in Parents of Children With Autism and Intellectual Disability: Evidence From the Impacts of the COVID-19 Pandemic on Family's Quality of Life and Parent-Child Relationships

    Dec 1, 2022, 00:00

  • CO52 Impact of Digital Interventions on Maintenance Treatment Adherence in Asthma: A Systematic Literature Review (SLR) and Meta-Analysis

    Dec 1, 2022, 00:00

  • RWD105 Clinical Differences and Patient Reported Outcomes Between Insufficient Responders and Responders to Prescribed Acute Migraine Treatment: Results From a Real-World Patient Survey in China

    Dec 1, 2022, 00:00

  • PCR153 A Comparison of Utility Values Generated Using Different Methods From the Phase II Vision Trial of Tepotinib for Patients With Non-Small Cell Lung Cancer (NSCLC) Harboring MET Exon 14 (METex14) Skipping

    Dec 1, 2022, 00:00

  • HTA22 ITC Appraisal by French HTA Committees: Comprehensive Review and Comparison

    Dec 1, 2022, 00:00

  • PCR266 Determinants of Emotional Distress Among Cancer Patients in Portugal: A Cross-Sectional Study

    Dec 1, 2022, 00:00

  • EE91 Economic Evaluation of Durvalumab for the Treatment of Patients With Stage III Unresectable Locally Advanced Non-Small Cell Lung Cancer Whose Disease Has Not Progressed After Platinum-Based Chemoradiation Therapy

    Dec 1, 2022, 00:00

  • HTA186 Cost-Effectiveness Analysis of Tirbanibulin for the Treatment of Actinic Keratosis From a Scottish NHS Perspective

    Dec 1, 2022, 00:00

  • HTA62 One Size Fit All? The Impact of EUnetHTA Joint Clinical Assessments on National Reimbursement

    Dec 1, 2022, 00:00

  • PCR250 Measuring Quality of Life of Patients With Age-Related Macular Degeneration in a Bulgarian Ophthalmic Clinic

    Dec 1, 2022, 00:00

  • EE283 Health Economic Impact of Medication Non-Adherence to Direct Oral Anticoagulants in Austria

    Dec 1, 2022, 00:00

  • EE652 Cost Effectiveness Analysis of Pembrolizumab for the Treatment of Advanced or Metastatic Renal Cell Carcinoma

    Dec 1, 2022, 00:00

  • EPH186 Public Health Impact of Immunotherapies in Advanced Cancers in Fran A National Retrospective Estimate Until End of 2020

    Dec 1, 2022, 00:00

  • MSR128 Swedish Nationwide Register Data as a Low-Cost Resource to Detect Drug-Repurposing Signals: A Study on De Novo Metastatic Breast Cancer Patients

    Dec 1, 2022, 00:00

  • OP14 Racial and Ethnic Minority Inclusion in Clinical Outcome Assessment (COA) Research: A Reflection on Current Practices

    Dec 1, 2022, 00:00

  • SA21 A Multicountry Innovative Approach to Obtain Strategic Patient Journey Insights From External Stakeholders in a New Therapeutic Rare Disease Area

    Dec 1, 2022, 00:00

  • EE612 Healthcare Resource Utilization and Costs Among Patients With Chronic Obstructive Pulmonary Disease in the United States

    Dec 1, 2022, 00:00

  • HTA179 Research on Assessment Mechanism of Online Diagnosis and Treatment Behavior in China

    Dec 1, 2022, 00:00

  • HPR144 TNF-Alfa Inhibitor Biosimilars: Qualitative Analysis of Uptake Determinants in Southern European Hospital Markets

    Dec 1, 2022, 00:00

  • EE141 Cost-Effectiveness of TP53 and IGHV Biomarker Testing Prior to First-Line Treatment With Novel Agents for Chronic Lymphocytic Leukemia

    Dec 1, 2022, 00:00

  • RWD58 Coding of Multiple Sclerosis Subtypes in German Administrative Claims Data: A Validation Study Using the MSDS-AOK PLUS Linked Database

    Dec 1, 2022, 00:00

  • HPR204 Role of Access-Reach Integration Framework (ARIF) in Optimizing Health Governance in Egypt – Health Policy Conceptual Paper

    Dec 1, 2022, 00:00

  • Exploring the Impact of Cancer Treatment on Patients' Quality of Life

    Dec 1, 2022, 00:00

  • CO9 Impact of Patient Blood Management (PBM) on the Reduction of Transfusion Requirements and Length of Hospital Stay in Patients Undergoing Major Planned Orthopedic in Germany

    Dec 1, 2022, 00:00

  • PCR217 The Impact of Poor Medication Adherence on Clinical Outcomes and Health Resource Use in Hypertension and/or Dyslipidaemia: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • HSD78 Systemic Amyloid Light Chain (AL) Amyloidosis Patient Experience Research

    Dec 1, 2022, 00:00

  • HSD43 COPD Patients Receiving Fixed or Open-Label Triple Therapy: Initiation and Persistence of Treatment Based on Data From a Real-World Ambulatory Medicalized Database in France

    Dec 1, 2022, 00:00

  • HTA135 Accessibility and Inclusivity for People Participating in Health Preference Research: How Does the Mode of Administering an Interview Impact on Time Trade-Off Studies?

    Dec 1, 2022, 00:00

  • EE47 Micro-Costing of Hematopoietic Cell Transplantation, Graft-Versus-Host Disease and Veno-Occlusive Disease Associated with the Treatment of Acute Myeloid Leukemia in Argentina

    Dec 1, 2022, 00:00

  • CO176 Enriching Real World Evidence Insights Through QSAR Based Exposure Definitions

    Dec 1, 2022, 00:00

  • EE151 Health Utilities Associated With Sacituzumab Govitecan (SG) for Treating Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer (MTNBC)

    Dec 1, 2022, 00:00

  • PCR12 Health-Related Quality of Life in German Early Benefit Assessment of Cancer Drugs: How Evidence-Based Are the Instruments Used?

    Dec 1, 2022, 00:00

  • HSD79 Physicians’ Experience and Perceptions of Tetrabenazine for the Treatment of Tardive Dyskinesia

    Dec 1, 2022, 00:00

  • EE181 Cost-Effectiveness of Single-Pill Combination Versus Free-Equivalent Combination in the Management of Hypertension

    Dec 1, 2022, 00:00

  • PCR242 Understanding the Real-World Experience of People With Haemophilia A Receiving Turoctocog Alfa Pegol (N8-GP): Results From a Patient Experience Survey

    Dec 1, 2022, 00:00

  • HSD73 First- and Second-Line Treatment Patterns in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: A Chart Review Study in Three Countries

    Dec 1, 2022, 00:00

  • PCR272 Attitudes Towards Coronavirus Vaccination Among the Hungarian Population

    Dec 1, 2022, 00:00

  • HPR168 Lessons Learned From NOACs and CV Drugs That Have Launched in the EU5, US, JP and BR? An HTA Review and Evidence Generation Standpoint

    Dec 1, 2022, 00:00

  • EE623 Cost-Minimization Analysis of a High Concentration Adalimumab Biosimilar: The Greek Context

    Dec 1, 2022, 00:00

  • PCR58 The Use of Argumentation Based Synthesis to Interrogate Evidence to Support Treatment Decisions Reflecting Individual Preferences

    Dec 1, 2022, 00:00

  • PCR276 Difficulties of Elimination Diets - Experiences of Allergy / Intolerance Among Young Adults

    Dec 1, 2022, 00:00

  • EE237 Reimbursable Digital Healthcare Applications (DiGAs) in Germany: Price Developments and Payer Perspective

    Dec 1, 2022, 00:00

  • MSR94 An Exploration of How Influential Digitisation Approaches Are in Their Impact on Survival Estimates for Health Technology Assessment (HTA)

    Dec 1, 2022, 00:00

  • HTA273 A Health Technology Assessment of Three Personalized Nutrition Interventions Using the Eunethta HTA Core Model

    Dec 1, 2022, 00:00

  • P39 Does the Choice of Modelling Approach Matter When Modelling Stroke Prevention Therapy?

    Dec 1, 2022, 00:00

  • RWD119 Exploring the Relationship Between Prophylactic Infusion Frequency and Patient Utility for People With Haemophilia in Europe

    Dec 1, 2022, 00:00

  • PCR168 The Changing Face of Qualitative Interviewing in Clinical Outcome Assessments Research: Conducting Qualitative Interviews Post COVID-19

    Dec 1, 2022, 00:00

  • PCR112 Expected Pricing and Access Hurdles in the US for Novel Rheumatoid Arthritis Therapies

    Dec 1, 2022, 00:00

  • SA40 Outcomes for Patients with Microsatellite Instability-High Metastatic Colorectal Cancer in the Real World Treated with Standard of Care Versus Patients Treated with Nivolumab Plus Low-Dose Ipilimumab in CheckMate 142

    Dec 1, 2022, 00:00

  • HSD114 Reductions in Travel Time and Carbon Dioxide Emissions Arising From Patient Transportation to Hospitals in England for Treatment With Intravenous Iron: An Analysis Comparing Ferric Derisomaltose With Ferric Carboxymaltose

    Dec 1, 2022, 00:00

  • HSD94 A Novel Method to Measure Health

    Dec 1, 2022, 00:00

  • EE486 Budget Impact Analysis of Cenobamate as Novel Adjunctive Treatment for FOS in Epilepsy Patients Inadequately Controlled With at Least Three Anti-Seizure Medications for the Belgian Healthcare Payer

    Dec 1, 2022, 00:00

  • EE101 Comparison of Two French Cost-Effectiveness Opinions for the Same First-Line Treatment Combination in Renal Cell Carcinoma

    Dec 1, 2022, 00:00

  • HPR136 The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health – A Systematic Review of Canadian Studies

    Dec 1, 2022, 00:00

  • RWD164 The Impact of the COVID-19 Pandemic on Patients With Type 2 Diabetes in Gree Results From a Real-World Study

    Dec 1, 2022, 00:00

  • HTA149 Early Access Reform in Fran Descriptive Analysis of First EAP Decisions

    Dec 1, 2022, 00:00

  • EE215 Pharmacoeconomic Analysis of Adjuvant Nivolumab for Patients With Resected Esophageal or Gastroesophageal Junction Cancer in Switzerland

    Dec 1, 2022, 00:00

  • CO136 Outcomes of Ceramic Versus Metal Heads After Primary Hip Hemiarthroplasty in a National Cohort Up to 10 Years of Follow-up

    Dec 1, 2022, 00:00

  • EPH107 Treatment Landscape for Patients With Advanced Systemic Mastocytosis in Germany in 2015 to 2020 Based on Claims Data Analysis

    Dec 1, 2022, 00:00

  • EPH169 Global Epidemiology, Humanistic Burden, and Economic Burden of Astigmatism: A Systematic Literature Review

    Dec 1, 2022, 00:00

  • MSR135 Alternative Methods for Sampling Ordered Parameters in Probabilistic Sensitivity Analysis (PSA)

    Dec 1, 2022, 00:00

  • EPH68 Epidemiological Impact of Generalized SARS-COV-2 Vaccination of Children Aged 5 to 11

    Dec 1, 2022, 00:00

  • MSR46 A Bayesian Hierarchical Modelling Approach for Indirect Comparison of Response Outcomes in Histology-Independent Therapies

    Dec 1, 2022, 00:00

  • PCR65 Development of a Patient-Reported Outcome Measure in Wilson Disease

    Dec 1, 2022, 00:00

  • HTA212 Real-Time Delphi Consultation on Medication Adherence Technologies: Consistency of Views Among Different Stakeholder Groups

    Dec 1, 2022, 00:00

  • EE285 Development of a Simulation Model for the Cost-Utility Analysis of Upright Intervention Promoting Resilience in Adolescents

    Dec 1, 2022, 00:00

  • HPR40 Cost-Effectiveness and Budget Impact of Baloxavir Marboxil in the Netherlands Based on Post-COVID Influenza Season Scenarios

    Dec 1, 2022, 00:00

  • EE492 Cost-Effectiveness of Dabigatran for Thromboembolic Events Prevention in Atrial Fibrillation Patients

    Dec 1, 2022, 00:00

  • HSD52 Demonstration of the Kitagawa Decomposition to Understand Racial/Ethnic Disparities by Partitioning Within- and Between-Hospital Mean Effects

    Dec 1, 2022, 00:00

  • EE458 Modelling Long-Term Clinical Outcomes of Patients with Transfusion-Dependent Beta-Thalassemia in the United States

    Dec 1, 2022, 00:00

  • CO151 Estimating the Benefit of Esketamine Nasal Spray Versus Real-World Treatment on Patient-Reported Functional Remission: Results From the Iceberg Study

    Dec 1, 2022, 00:00

  • CO1 The Health Outcome Analysis of Sintilimab for the First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: According to the Eq-5D-5L

    Dec 1, 2022, 00:00

  • MSR122 Examining the Relationships and the Effects of Gender and Grade on Seven Widely Used Well-Being Scales

    Dec 1, 2022, 00:00

  • RWD155 Index Date Validation in OCEANIA a Real-World Database Study – The Importance of Looking Back

    Dec 1, 2022, 00:00

  • CO93 Rates of Disease-Related Hospitalization and Colectomy in Real-World Patients With Ulcerative Colitis on Anti-Tnf Agents: Evidence From a Systematic Review

    Dec 1, 2022, 00:00

  • EE62 The Societal Burden of Bardet-Biedl Syndrome in the United States

    Dec 1, 2022, 00:00

  • RWD36 Comparison of True Versus Apparent Survival in Patients With Metastatic Non-Small Cell Cancer Treated in the Real-World Setting

    Dec 1, 2022, 00:00

  • HTA251 Determining Factors of Simplified Evaluations in Norwegian Health Technology Assessments

    Dec 1, 2022, 00:00

  • EPH160 Burden of Illness (BOI) and Paucity of Treatment of the Mosquito-Borne Chikungunya Virus (CHIKV)

    Dec 1, 2022, 00:00

  • EE471 Cost Effectiveness of Newborn Screening (NBS) for Spinal Muscular Atrophy (SMA) in England

    Dec 1, 2022, 00:00

  • EPH77 Prevalence of Common Chronic Diseases Among Overweight and Obese Adults in Greece

    Dec 1, 2022, 00:00

  • SA34 Identifying References in a Literature Review Update: A Study Exploring Three Alternative Approaches

    Dec 1, 2022, 00:00

  • CO163 The Increasing Use of Population-Adjusted Indirect Comparisons in the NICE Health Technology Assessment (HTA) Submission Process and the Response to These Methods

    Dec 1, 2022, 00:00

  • HPR164 Exploring Timelines for New Medicines Reimbursed in Ireland in 2021

    Dec 1, 2022, 00:00

  • RWD34 Comparison of ICU/Ventilator Usage Among Vaccinated and Unvaccinated COVID-19 Patients

    Dec 1, 2022, 00:00

  • HPR114 Is No Therapy a Therapy? Effects of Watchful Waiting as Appropriate Comparator Therapy for New Drugs on Benefit Assessment and Pricing in Germany

    Dec 1, 2022, 00:00

  • HTA87 Evaluating the Framework and Evolution of the Italian Ministry of Health HTA Reports

    Dec 1, 2022, 00:00

  • P7 A Pragmatic Framework to Tackle the Challenge of Developing Concise Attribute Lists for Stated Patient Preference Surveys

    Dec 1, 2022, 00:00

  • MSR87 Understanding Feline Pruritis From the Pet Owners Perspective: Can Social Media Listening Identify and Describe a Pet Patients Pathway Through a Disease Process in Veterinary Medicine?

    Dec 1, 2022, 00:00

  • EE617 Cost-Effectiveness of Meningococcal B Vaccination in the Netherlands

    Dec 1, 2022, 00:00

  • PCR279 Value-Based Assessment of Clinical Trial Outcomes: A Hypothetical Example Using the Childhood Autism Rating Scale in Autism Spectrum Disorder

    Dec 1, 2022, 00:00

  • EPH139 Deprivation and Access to Care Among Patients With Melanoma in the UK

    Dec 1, 2022, 00:00

  • HPR176 Reimbursement of Antineoplastic and Immunomodulating Agents in Turkey: Comparison With Approvals of the FDA Between 2010-2021

    Dec 1, 2022, 00:00

  • RWD168 ER Visits, Procedures Conducted, and Associated Cost

    Dec 1, 2022, 00:00

  • RWD114 Investigating the Impacts of Comorbid Conditions on Costs and Length of Stay in Secondary Care Among Adults Infected With Influenza in England

    Dec 1, 2022, 00:00

  • EE325 Cost-Effectiveness of Lung Cancer Screening With Low Dose Computed Tomography in Hungary

    Dec 1, 2022, 00:00

  • EE341 Economic Evaluations of Technologies for the Treatment of Rare Diseases in Latin America and Southeast Asia: A Scoping Review

    Dec 1, 2022, 00:00

  • EE314 Economic Impact of Feno Testing on the Italian Population With Asthma

    Dec 1, 2022, 00:00

  • CO18 Exploring Endpoint Correlation Between Progression Free Survival (PFS) and Overall Survival (OS) in Previously Untreated Metastatic Melanoma Using Pseudo Individual Patient Data (IPD)

    Dec 1, 2022, 00:00

  • CO157 The Clinical and Economic Impact of Nationwide Insurance Coverage for Next-Generation Sequencing in Advanced Ovarian Cancer: A Retrospective Observational Study Using the Nationwide Database in South Korea

    Dec 1, 2022, 00:00

  • PCR180 Real-World Impact of Patient-Reported Outcome Measurement on Overall Survival and Healthcare Resource Utilization in Cancer Patients

    Dec 1, 2022, 00:00

  • EPH16 Antidiabetic Drugs and the Incidence of Parkinson's Disease in Patients With Type 2 Diabetes: A Case-Control Study

    Dec 1, 2022, 00:00

  • MSR143 How Uncertain Is Uncertainty Testing in Budget Impact Models?

    Dec 1, 2022, 00:00

  • HTA70 Four Is the New Seven: The Application of New Routing Criteria for NICE’S Highly Specialised Technology Programme

    Dec 1, 2022, 00:00

  • PCR119 Who We Are Matters: Inclusive Demographic Data Collection in Patient-Centered Outcomes Research

    Dec 1, 2022, 00:00

  • HTA197 What Drives the Limited Scope of French National Authority for Health (HAS) Economic Opinions for Rare Diseases in France?

    Dec 1, 2022, 00:00

  • EPH193 Assessment of Diuretic Drug Consumption in Ukraine

    Dec 1, 2022, 00:00

  • EE104 Appraisal of the Multi-Criteria Decision Analysis Method to Improve Value Assessment of New Therapies

    Dec 1, 2022, 00:00

  • EPH144 The Impact of COVID-19 Pandemic on the Detection and Management of Cancer: A German Claims Data Analysis

    Dec 1, 2022, 00:00

  • HTA176 A Systematic Literature Review of Rationale, Methods, and Use of Cost-Effectiveness Thresholds in Health Technology Assessments

    Dec 1, 2022, 00:00

  • PCR15 Throat Pain and Discomfort Associated With Transesophageal Echocardiography in Chinese Atrial Fibrillation Patients With Planned Radio-Frequency Ablation: A Patient Survey Study

    Dec 1, 2022, 00:00

  • HPR27 Is It Possible to Anticipate the Risk of Major Reservation Issued by the CEESP? A Retrospective Analysis of Published Opinions

    Dec 1, 2022, 00:00

  • RWD87 Association Between Functional Endpoints and Quality-of-Life Outcomes in Huntington's Disease Gene Carriers: Results From a Real-World Data Analysis of the Enroll-HD Global Registry

    Dec 1, 2022, 00:00

  • PCR113 Are Patient and General Population Samples Fundamentally Different? An Exploration Using a Discrete Choice Experiment (DCE)

    Dec 1, 2022, 00:00

  • EPH124 Prediction Model to Evaluate the Impact of a Next Generation Bivalent Omicron-Containing COVID-19 Booster (MRNA.1273.214) on Hospitalizations in Adults in Germany

    Dec 1, 2022, 00:00

  • EE233 Cost-Effectiveness of Ravulizumab Compared with Eculizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) in the Netherlands

    Dec 1, 2022, 00:00

  • EE549 Hospital Care and Medical Costs of Septic Arthritis in Spain: A Retrospective Multicenter Analysis

    Dec 1, 2022, 00:00

  • HPR2 Criteria to Define Rare Diseases and Orphan Drugs Systematic Literature Review

    Dec 1, 2022, 00:00

  • HTA142 Potential Impact of Biomarker Guided-Decisions on Overtreatment in Immunotherapy for Non-Small Cell Lung Cancer Patients

    Dec 1, 2022, 00:00

  • HSD101 Policy Analysis of Eight Failed Telemedicine Experiments in the Paris Region

    Dec 1, 2022, 00:00

  • EE401 Cost-Effectiveness of OMNI® Surgical System Versus iStent Inject® for the Treatment of Primary Open-Angle Glaucoma in the United States

    Dec 1, 2022, 00:00

  • HTA173 Productivity Losses in Pharmacoeconomic Guidelines in Europe and Asia: A Qualitative Review of Guidelines

    Dec 1, 2022, 00:00

  • HSD25 Occupational Burnout Among Pediatric Neurologists Is Associated with Therapeutic Inertia in the Management of Spinal Muscular Atrophy

    Dec 1, 2022, 00:00

  • SA12 A Mixed-Methods Review of the Systematic Reviewer's Inter-Reviewer Reliability Using the Kappa Statistic

    Dec 1, 2022, 00:00

  • EE42 The Societal Burden of Seasonal Influenza on Working-Aged Adults in The United Kingdom: Results From an Online Survey of The General Public

    Dec 1, 2022, 00:00

  • PCR221 Health-Related Quality of Life Among Working Nurses in Hong Kong: The Role of Resilience Under the COVID-19 Pandemic

    Dec 1, 2022, 00:00
  • «
  • 31
  • 32
  • 33
  • 34 (current)
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • »